Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranibizumab for Non-leaking Macular Cysts in Retinal Dystrophy
NCT03763227Phase 2Completed
- Sponsor
- Sultan Qaboos University
- Start
- Jul 2015
- Primary completion
- Aug 2019
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
01
Overview
A Phase 2 trial of ranibizumab in retinal dystrophy, cystoid macular edema (CME), sponsored by Sultan Qaboos University. Started Jul 2015; status: completed.
02
Drugs
ranibizumab
03
Conditions
retinal dystrophycystoid macular edema (CME)
Beyond the preview
Go deeper on NCT03763227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03763227.